Please note: We have made changes to the Translational Award. The maximum allowable budget for the overall project has increased to £750,000.
Who can apply
- The principal investigator will be a researcher working in an established research institution in the UK.
What we are looking for
- The project should be novel, inventive and address an unmet clinical need.
- The project should not be addressing a fundamental scientific hypothesis.
- Projects should be in the field of cardiovascular disease, stroke, vascular dementia and diabetes.
- The award can be used for development of therapeutics, medical devices, imaging technologies, diagnostics and digital solutions.
- The project should result in a product, technology or intervention that is ready for market development.
- The project should include:
- Robust proof of concept data
- Non-overlapping milestones, each with a clear go/no-go decision
- A proposed route to market
- An understanding of the Intellectual Property (IP) landscape
- A strategy to navigate the regulatory process
The maximum allowable budget is £750,000 for the overall project - with clear milestones and the cost for each milestone identified and justified.
Are you unsure whether your research is at the appropriate stage or is eligible for funding? Please contact a member of the Research Translation team.
If BHF is the most appropriate follow on funder then we may provide further support beyond the Translational Award.
Award may include
The award can be used flexibly. We will fund staff salaries (excluding PhD studentships), consumables and essential research equipment, consultancy fees, outsourcing to contract research organisations and relevant training courses.
Please find here more information on costing a grant.
Longer term project goals
In your application, it is important to consider the entire route to commercialisation for your technology and not just what will be funded by this particular Translational Award.
We require that you work with your institution's Technology Transfer Office (TTO) to develop the commercial case for the application.
Providing this information gives the BHF and subsequent investors the confidence that the project is well designed and has the best chance of success.
The MHRA Innovation Office provides a free, informal service that can help with your regulatory queries.
How to apply
Applications are assessed in a two-stage process:
1. Submit your preliminary application
All preliminary applications will be considered by the Translational Awards Committee. Successful applicants will be invited to submit a full application.
Please complete the Preliminary Application Form referring to Translational Award Preliminary Application Guidelines and Translational Award Terms & Conditions.
Applications must be completed in partnership with your institution's TTO.
2. Submit your full application
Successful preliminary applications will be asked to complete a full application form. This will be assessed on scientific merit and commercial viability by external peer reviewers and by the Translational Awards Committee.
Specific guidance for preparation of full applications will be provided along with outline application feedback.
Does your proposal includes animal work or human tissue? Please complete a questionnaire on experiments on animals form (EXA) or a questionnaire on experiments involving human subjects form (EXH) as necessary.
April 2019 round
- Preliminary application deadline – 15th April 2019
- Full application deadline – 11th September 2019
October 2019 round
- Preliminary application deadline – 15th October 2019
- Full application deadline – 6th March 2020
Applications must be received by midday. Late submissions will not be considered.
We will acknowledge receipt of your application within 1 working week. We will advise when you can expect the result. BHF reserve the right to change the deadline dates. We recommend that you check this page on a regular basis to take note of any changes.
Please allow 7 months from preliminary application submission to decision.
Project management and reporting
Successful Translational Awards require efficient management and reporting to ensure that the project stays on target. A project manager may be appointed by the BHF to assist with this.
On completion of each milestone period, a written progress report should be submitted and will be reviewed by selected members of the Translational Awards Committee (additional discussion in face-to-face meeting(s) and/or through telephone or Skype call(s) may be requested). They will indicate whether the milestone has been met satisfactorily.
Continuation or cessation of funding for work towards subsequent milestone(s) is subject to such assessment and, where necessary, decisions will be taken by Chair’s action outside of the Committee meetings schedule, to avoid delay.
Hear from the experts
We previously held a workshop, ‘How to Translate your Research’. Committee members and industry experts discussed what they look for in a good project. Highlights are included in the video below: